A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation

Specialty Areas:
Date: June 28, 2023
Authors:
Joy S Sclamberg, Karen Schmitz, Kelly Burgess, Kelsey T Danley, Lela E Buckingham, Lydia Usha, Ritu Ghai, Timothy Kuzel
Journal: The Oncologist
Journal Volume: 26